BSE filing, NSE: AUROLAB. Summary written from the filing by ALFA Finder's alert engine.
Auro Laboratories Ltd: key numbers
- Share price
- ₹229.40
- Market cap
- ₹143.0 Cr
- Revenue (annual)
- ₹32.61 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 30.5×Sector 46.1×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Auro Laboratories Ltd
All →Auro Laboratories Other Announcement
Auro Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Auro Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Auro Laboratories Ltd reported revenue from operations of ₹8.8 Cr (+214.3% YoY) and net profit of ₹1 Cr for Q1 FY27.
- Key figure
- Net profit ₹1 Cr
Auro Laboratories Annual General Meeting
Auro Laboratories Limited held its 37th Annual General Meeting on August 11, 2026, via video conferencing. The company conducted all items of business as listed in the notice.
Auro Laboratories Board Meeting Date
Auro Laboratories Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Auro Laboratories Annual General Meeting
Auro Laboratories has scheduled its 37th Annual General Meeting for August 11, 2026. Agenda includes adopting financial statements and re-appointing Mr. Kiran Kulkarni as Whole-Time Director.
Auro Laboratories Annual Report
Auro Laboratories released its Annual Report for FY 2025-26. The 37th Annual General Meeting is scheduled for August 11, 2026, via video conferencing.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.